Feb 2006;26(1):32-9
SU11274 inhibition of c-MET/HGF signalling We have previously characterised and described the efficacy of the specific small molecule inhibitor of c-MET (Sattler et al, 2003
When I treat patients in the diabetes clinic, I see a huge variation in response to these GLP-1-based medications and it is difficult to predict this response clinically, Umapathysivam said
The reduction in Agt and AT1a expression implies a suppression of Angiotensin II (Ang II) activity, which is hypothesized to contribute to fibrosis.This hypothesis seems plausible as angiotensin receptor blockers and ACE inhibitors have long been studied for their potential to slow down cardiac modeling/fibrosis and researchers suggest they are first line of prevention for fibrosis
You can eat your way to higher glutathione levels, per Fernando
In health, GLP-1 stimulates the synthesis and secretion of insulin from pancreatic -cells in a glucose-dependent manner (i.e., it is activated when blood glucose levels are elevated, typically in the postprandial state)
